Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Lineage Cell Therapeutics (LCTX) Q4 2023 Earnings
LCTX
-1.74%
7
Mar
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.04
-0.04
-0.03
-0.03
Details
Expected EPS
-0.042857
Actual EPS
-0.03
Surprise EPS
0.01
Surprise Percent
+30%
Description
Lineage Cell Therapeutics (LCTX) has reported earnings of -0.03 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login